Learn more

WANG DAOWEN

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    178,774
  • Filing trend
    ⇩ 100.0%
About

WANG DAOWEN has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in China and United States. Its main competitors in its focus markets biotechnology, organic fine chemistry and pharmaceuticals are AMOY DIAGNOSTICS CO LTD, RUBICON GENOMICS INC and BEIJING BERRY GENOMICS CO LTD.

Patent filings in countries

World map showing WANG DAOWENs patent filings in countries
# Country Total Patents
#1 China 11
#2 United States 1

Patent filings per year

Chart showing WANG DAOWENs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wang Daowen 12
#2 Chen Chen 5
#3 Li Zongzhe 3
#4 Yang Shenglan 2
#5 Wang Feng 2
#6 Huang Jin 2
#7 Xiao Ruiping 2
#8 Li Huaping 2
#9 Jiang Jiangang 1
#10 Liu Juan 1

Latest patents

Publication Filing date Title
CN107252491A Medicine and its screening technique and preparation method for treating heart failure
CN106676637A DNA library for detecting multiple osteochondromas (MO) pathogenic genes and application of DNA library
CN106319058A DNA library for detecting idiopathic pulmonary fibrosis pathogenic genes and application of DNA library
CN106350589A DNA library for detecting pathogenic genes of genetic vascular diseases and application thereof
CN105586405A Method for detecting gene polymorphism of ADRB2 and GRK5 and clinical application
CN105586406A Method for detecting gene polymorphism of ADRB1 and GRK5
CN105497030A Trimetazidine new use in prevention and treatment of sepsis-caused cardiac insufficiency
CN104988216A Serum miRNA relevant to chronic heart failure and application of serum miRNA
CN102605076A Quick genotyping method for guiding Warfarin utilization starting dose and kit
CN102965347A Preparation method of recombinant adeno-associated virus expressing hsa-miR-21<*> and application in treatment of hypertension
CN102965429A Application of microRNA-320(miR-320a) and its antisense nucleotide in diagnosis, prevention and treatment of cardiovascular diseases